Articles with public access mandates - Antonio DanieleLearn more
Not available anywhere: 10
Review
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
F Panza, D Seripa, V Solfrizzi, BP Imbimbo, M Lozupone, A Leo, ...
Expert Opinion on Emerging Drugs 21 (4), 377-391, 2016
Mandates: Government of Italy
Review
Physical frailty, multimorbidity, and all-cause mortality in an older population from southern Italy: results from the Salus in Apulia study
F Castellana, L Lampignano, I Bortone, R Zupo, M Lozupone, C Griseta, ...
Journal of the American Medical Directors Association 22 (3), 598-605, 2021
Mandates: US National Institutes of Health, Government of Italy
Review
Phytochemicals in the treatment of Alzheimer's disease: a systematic review
G D'Onofrio, D Sancarlo, Q Ruan, Z Yu, F Panza, A Daniele, A Greco, ...
Current Drug Targets 18 (13), 1487-1498, 2017
Mandates: Government of Italy
Review
Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
D Seripa, V Solfrizzi, BP Imbimbo, A Daniele, A Santamato, M Lozupone, ...
Expert Review of Neurotherapeutics 16 (3), 259-277, 2016
Mandates: Government of Italy
Review
The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
F Panza, D Seripa, M Lozupone, V Solfrizzi, BP Imbimbo, MR Barulli, ...
Expert opinion on biological therapy 18 (1), 25-35, 2018
Mandates: Government of Italy
Review
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
M Lozupone, BP Imbimbo, C Balducci, F Lo Vecchio, P Bisceglia, ...
Alzheimer's & Dementia 19 (1), 353-368, 2023
Mandates: Government of Italy
Review
Depressive and biopsychosocial frailty phenotypes: impact on late-life cognitive disorders
F Panza, V Solfrizzi, R Sardone, V Dibello, F Castellana, R Zupo, ...
Journal of Alzheimer's Disease 94 (3), 879-898, 2023
Mandates: Government of Italy
Review
Vitamin D in the development and progression of alzheimer’s disease: Implications for clinical management
F Panza, M La Montagna, L Lampignano, R Zupo, I Bortone, F Castellana, ...
Expert Review of Neurotherapeutics 21 (3), 287-301, 2021
Mandates: US National Institutes of Health, Government of Italy
Review
Apolipoprotein E genotype, inflammatory biomarkers, and non-psychiatric multimorbidity contribute to the suicidal ideation phenotype in older age. The Salus in Apulia Study
M Lozupone, R Donghia, R Sardone, A Mollica, G Berardino, ...
Journal of Affective Disorders 319, 202-212, 2022
Mandates: US National Institutes of Health, Government of Italy
Review
Late-onset depression but not early-onset depression may increase the risk of all-cause mortality in older age: 8-year follow-up of the Salus in Apulia Study
M Lozupone, F Castellana, R Sardone, G Berardino, A Mollica, R Zupo, ...
Journal of the American Medical Directors Association 24 (5), 679-687, 2023
Mandates: US National Institutes of Health
Available somewhere: 38
Review
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Mandates: US National Institutes of Health, Motor Neurone Disease Association, UK, UK …
Review
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, National …
Review
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Review
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?
MG Rizzone, A Fasano, A Daniele, M Zibetti, A Merola, L Rizzi, C Piano, ...
Parkinsonism & related disorders 20 (4), 376-381, 2014
Mandates: Government of Italy
Review
Tau‐Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
F Panza, V Solfrizzi, D Seripa, BP Imbimbo, M Lozupone, A Santamato, ...
BioMed research international 2016 (1), 3245935, 2016
Mandates: Government of Italy
Review
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
Mandates: US National Institutes of Health, Banking Foundation "la Caixa", National …
Review
Oral frailty and its determinants in older age: a systematic review
V Dibello, R Zupo, R Sardone, M Lozupone, F Castellana, A Dibello, ...
The Lancet Healthy Longevity 2 (8), e507-e520, 2021
Mandates: US National Institutes of Health, Government of Italy
Review
Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides
M Beghi, E Butera, CG Cerri, CM Cornaggia, F Febbo, A Mollica, ...
Neuroscience & Biobehavioral Reviews 127, 193-211, 2021
Mandates: Government of Italy
Review
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ...
The Lancet Neurology 20 (3), 182-192, 2021
Mandates: US National Institutes of Health, German Research Foundation, Volkswagen …
Review
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease
H Holstege, M Hulsman, C Charbonnier, B Grenier-Boley, O Quenez, ...
Nature genetics 54 (12), 1786-1794, 2022
Mandates: US National Institutes of Health, National Fund for Scientific Research …
Publication and funding information is determined automatically by a computer program